Sarlósejtes vérszegénység: vizsgálatok itt: Hollandia
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleSafety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 63 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07224360 · EU 2025-521154-42-00 - 3. fázisTaking peopleThe Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Where
- Rotterdam
- Életkor
- 10 év to 65 év
- People
- 192 worldwide
- Run by
- Sanofi
See details and how to joinNCT06975865 - 2. fázisBefejeződöttSafety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Where
- Amsterdam, Rotterdam, Utrecht
- Életkor
- 12 év and over
- People
- 70 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06699849 · EU 2024-513440-29-00 - 3. fázisNot yet taking people in HollandiaA research study to evaluate how well etavopivat works in children with sickle cell disease
- Where
- Amsterdam
- Életkor
- Up to 17 év
- People
- 27 worldwide
- Run by
- Novo Nordisk A/S
See details and how to join2025-524464-38-00 - 3. fázisTaking peopleA Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Where
- Amsterdam, Rotterdam, 's-Gravenhage, Utrecht
- Életkor
- 12 év and over
- People
- 510 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06612268 · EU 2023-509175-16-00 - 3. fázisNot yet taking people in HollandiaThe Effect of Mitapivat on Cerebral Perfusion and Oxygen Metabolism in Sickle Cell Disease
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 20
- Run by
- Amsterdam UMC Stichting
See details and how to join2024-513528-41-02 - No phaseTaking peopleEffect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease
- Where
- Amsterdam
- Életkor
- 6 év to 18 év
- People
- 40
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT07001631